Drug Pipeline

JSKN003 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
1
Recruiting
1
Phase 3
3
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
2
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07384377 JSKN003 Versus Physician Choiced Treatment in Patients With HER2-positive and Advanced… HER2-positive Colorectal Cancer Not Yet Recruiting
Phase 2
NCT05582499 Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study… Breast Neoplasm Recruiting
NCT07545044 A Study of JSKN003 Versus Trastuzumab in Combination With Pertuzumab and Docetaxel as… HER2-positive Recurrent or Metastatic Breast Cancer Not Yet Recruiting
Phase 1/2
NCT05744427 Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors Advanced Solid Tumor Active, Not Recruiting
Sponsors Running JSKN003 Trials
Shanghai JMT-Bio Inc. (2) Fudan University (1) Jiangsu Alphamab Biopharmaceuticals Co., Ltd (1)
Disease Areas
Breast Cancer (2) Triple-Negative Breast Cancer (1) HER2-Positive Breast Cancer (1) Colorectal Cancer (1)
Get alerts when JSKN003 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free